What podcasts say about Medtronic
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Medtronic
20 statements · 15 positive · 1 negative · 3 mixed · 1 neutral
Medtronic is preferable to MiniMed for new investment.
“It's Medtronic. I would buy that one.”
Open the episode · Mad Money w/ Jim Cramer 10/14/26Listen at 38:31
Medtronic trades at fifteen times earnings.
“15 times earnings for Medtronic.”
Open the episode · Mad Money w/ Jim Cramer 10/14/26Listen at 38:34
Medtronic’s stock is expected to begin rising.
“now it's going to start going up.”
Open the episode · Mad Money w/ Jim Cramer 10/14/26Listen at 38:39
Cramer likes Medtronic but recommends buying gradually at lower prices.
“I like Medtronic, but I got to tell you, at 14 times earnings, I don't know what supports it. I buy a little and then wait a little more until it goes down.”
Open the episode · Mad Money w/ Jim Cramer 10/1/26Listen at 9:36
Buy a small Medtronic position and wait for a lower price.
“I buy a little and then wait a little more until it goes down.”
Open the episode · Mad Money w/ Jim Cramer 10/1/26Listen at 9:41
Medtronic’s business has substantially improved year over year.
“It is a vastly improved year-over-year business.”
Open the episode · 'Mad Money w/ Jim Cramer 9/8/26Listen at 5:15
Medtronic beat quarterly earnings and revenue estimates and raised fiscal 2027 guidance.
“Medtronic added around 1.5% after topping analysts' quarterly earnings and revenue estimates and raising fiscal 2027 guidance.”
Open the episode · Mulling Tech Earnings, Investors Watch Oil, YieldsListen at 7:07
Cramer declines to recommend buying Medtronic before its earnings report.
“I wish I could be aggressive in recommending Medtronic right on Monday morning, but I can't.”
Open the episode · Mad Money w/ Jim Cramer 5/29/26Listen at 7:22
Cramer may choose Medtronic after reviewing its upcoming earnings.
“Let's look at Medtronic after they report. And then that may be the one that we pull the trigger on.”
Open the episode · Mad Money w/ Jim Cramer 5/29/26Listen at 35:18
Medtronic is inexpensive at fifteen times earnings.
“By the way, it's 15 times earnings. That's very inexpensive.”
Open the episode · Mad Money w/ Jim Cramer 3/26/26Listen at 9:05
Medtronic is inexpensive at fifteen times earnings
“it's 15 times earnings. That's very inexpensive.”
Open the episode · Mad Money w/ Jim Cramer 3/26/26Listen at 9:05
Cramer recommends buying more Medtronic
“I would buy more, Tony.”
Open the episode · Mad Money w/ Jim Cramer 3/26/26Listen at 9:08
Medtronic's diabetes spinoff makes the remaining company more attractive.
“spinning this off makes, I think, the old Medtronic much more enticing.”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 20:45
Medtronic can focus on cardiovascular, neuroscience, and medical-surgical businesses.
“Medtronic can now focus on its three remaining businesses”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 23:01
Medtronic is resistant to recession.
“this thing's recession-proof.”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 25:40
Medtronic shares are inexpensive relative to earnings estimates.
“stock's cheap. It's trading 16 times this year's earnings estimates, less than 15 times next year's numbers.”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 26:02
Cramer is much more bullish on Medtronic after the diabetes separation.
“I am much more bullish on this stock than I have been in ages.”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 26:20
Medtronic is too cheap for investors to ignore.
“At these levels, I think the stock's simply too cheap to ignore.”
Open the episode · Mad Money w/ Jim Cramer 3/10/26Listen at 26:27
Medtronic’s AI-assisted colonoscopy has performed very successfully diagnostically.
“the AI has been a home run for this diagnostic.”
Open the episode · Mad Money w/ Jim Cramer 1/12/26Listen at 18:07
Pulse-field ablation will improve Medtronic’s gross margin over time.
“you're going to see it impact positively our gross margin as well.”
Open the episode · Mad Money w/ Jim Cramer 1/12/26Listen at 20:33
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.